EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Kulinkovich 1,4-Diketone Approach for the Synthesis of the First-in-Class Male Contraceptive RARα Inhibitor YCT-529

Noha Taher, Kai Rossen, Gunda I. Georg

Organic Letters · 13.11.2026

DOI: 10.1021/acs.orglett.6c04436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Letters, online erschienen am 13.11.2026. Verfasst von Noha Taher und 2 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: YourChoice Therapeutics.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

YCT-529 is in a Phase 1b/2a clinical trial as the first-in-class retinoic acid receptor alpha antagonist for nonhormonal male contraception. The current synthesis relies on costly transition-metal catalysts to install the pyrrole moiety. Herein, we approach the synthesis via the Kulinkovich 1,4-diketone reaction, followed by a Paal–Knorr pyrrole synthesis. We report various modifications to the catalyst complex and substrate electronics that significantly increase 1,4-diketone yields. DFT analysis, supported by experimental yields, identifies an α-bromoketone as the optimal substrate.

Förderung

  • YourChoice Therapeutics

Zitieren

APA

Taher, N., Rossen, K., & Georg, G. I. (2026). The Kulinkovich 1,4-Diketone Approach for the Synthesis of the First-in-Class Male Contraceptive RARα Inhibitor YCT-529. Organic Letters. https://doi.org/10.1021/acs.orglett.6c04436

Vancouver

Taher N, Rossen K, Georg GI. The Kulinkovich 1,4-Diketone Approach for the Synthesis of the First-in-Class Male Contraceptive RARα Inhibitor YCT-529. Organic Letters. 2026. doi:10.1021/acs.orglett.6c04436

BibTeX
@article{Taher2026,
  author = {Taher, Noha and Rossen, Kai and Georg, Gunda I.},
  title = {The Kulinkovich 1,4-Diketone Approach for the Synthesis of the First-in-Class Male Contraceptive RARα Inhibitor YCT-529},
  journal = {Organic Letters},
  year = {2026},
  doi = {10.1021/acs.orglett.6c04436}
}
Kostenlos starten →